Kelo Update — Lessons Learned?

Read this excellent Op-Ed piece from the New York Times about the questions recently revisited as a result of the decision of Pfizer to close its New Lodon facility before “redevelopment” occurred and leaving behind vacant land which victimized Suzette Kelo and her neighbors.

For another article in the New York Times on Pfizer’s departure from New London and its anticipated impacts upon the community, click here.

Pfizer’s abandonment of New London, and the questions it raises about the efficacy of using eminent domain powers in support of municipal redevelopment projects was also the subject of an editorial in the Star Ledger calling for eminent domain legislative reform in New Jersey.  Read the editorial.